Polymorphism in endostatin, an angiogenesis inhibitor, and prostate cancer risk and survival: A prospective study.

Source:http://linkedlifedata.com/resource/pubmed/id/19431146

Int. J. Cancer 2009 Sep 1 125 5 1143-6

Download in:

View as

General Info

PMID
19431146